samedan logo
 
 
 
spacer
home > pmps > autumn 2008 > universal clarity
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Universal Clarity

People with a visual impairment often experience problems in differentiating packets, with the increased standardisation of packaging sizes and shapes. They can also have problems with reading the instructions since they are often printed in a small typeface with poor visual quality. In order to alleviate these problems, the European Commission has issued a directive requiring suppliers of pharmaceutical products to incorporate braille labels and produce information leaflets in alternative formats. However, the associated standard has yet to be published, which leaves uncertainty about the detailed implementation of the directive.

Packaging poses significant problems for many older people. This is often due to an inability to read the label, understand its meaning or open the package without damaging the contents. Failure to take medicine correctly has been estimated to cost the US economy $100 billion per year (1).

THE VISUALLY IMPAIRED POPULATION

About 1.5 per cent of the population could be officially registered as ‘blind’ or ‘partially sighted’. Of these, around 0.4 per cent have to rely on non-visual methods to access information (2)...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Dr John Gill, OBE DSc FIET, is Chief Scientist at RNIB in the UK. He has worked for over 35 years in the area of scientific and technological research for people with disabilities. His research has included the design of fonts, public access terminals, tactile communication, orientation systems, automated production of braille and large print, smart card and biometric systems, and accessibility of information and communication technology systems and services. He has visited over 40 countries and written over 200 publications.
spacer
Dr John Gill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stoelzle Glass Group division Pharma – Health & Safety expands its product portfolio with Type II glass

The company also introduces a newly developed, innovative, stable and environmental conscious process for the inner surface treatment of moulded Type III glass containers.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement